Myelodysplastic Syndrome (MDS)
Myelodysplastic Syndrome (MDS) is a group of blood disorders caused by poorly formed or dysfunctional blood cells, leading to symptoms like fatigue, weakness, and an increased risk of infections.
Myelodysplastic Syndromes: Elritercept Treatment Study
We are testing elritercept to see if it can help reduce the need for blood transfusions in adults with certain types of myelodysplastic syndromes. The study will also look at how safe and tolerable the treatment is.
What diseases are being studied?
Health conditions and diseases that the clinical trial is designed to study and treat.
Anemia
Anemia is a condition where you lack enough healthy red blood cells to carry adequate oxygen to your body's tissues, causing symptoms like fatigue, weakness, and pale skin.
Who can participate in the clinical trial?
These questions help us understand your situation so we can let the trial team know whether you might be a potential match. This is not a medical evaluation and is not part of the official screening, the study doctor will make the final decision..
- Are you at least 18 years old?
- Do you have a diagnosis of MDS (myelodysplastic syndrome)?
- Are you currently pregnant or breastfeeding?
- Have you had any major surgery in the past 28 days?
- Do you have any known heart problems, like a history of heart failure or a heart attack?
What experimental substances are being tested?
Experimental substances that are being investigated in this clinical trial. These are not yet approved for general use.
Elritercept
What similar medicines might you know?
Don't worry if you don't know the medicines tested in the trial. There is a chance you have heard about the similar medicines. Check the list below to see if you are familiar with any of them.
Abtard
Adolax
Alivio
Where is the clinical trial being conducted?
Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.
Loading map...
Dr. Pencho Georgiev Ambulatory For Individual Practice For Medical Aid For Clinical Hematology EOOD
Plovdiv, Bulgaria
Military Medical Academy
Hematology Clinic
Sofia, Bulgaria
Specialized Hospital For Active Treatment Of Hematological Diseases EAD
First Department of Clinical Hematology
Sofia, Bulgaria
Sponsor: Takeda Development Center Americas Inc.
Last updated: Nov 26, 2025
Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.